analytical standard comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-10-03. Where a claim depends on a specific study, the study is described rather than over-claimed.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
In October 2003, the People's Republic of China commenced its first crewed spaceflight, Shenzhou 5. The astronaut, Yang Liwei, brought along with him and ate specially processed yuxiang pork (Chinese: 鱼香肉丝), Kung Pao chicken (Chinese: 宫保鸡丁), and Eight Treasures rice (Chinese: 八宝饭), along with Chinese herbal tea. Food made for this flight and the subsequent crewed flight in 2007 has been commercialized for sale to the mass market. At Tiangong space station, meals consisting of 120 different types of food, selected based on astronauts' preferences, are stored aboard. Staples including shredded pork in garlic sauce, kung pao chicken, black pepper beef, yuxiang shredded pork, pickled cabbage, and beverages, including a variety of teas and juices, are resupplied by trips of the Tianzhou-class robotic cargo spacecraft. Fresh fruits and vegetables are stored in coolers. Huang Weifen, the chief astronaut trainer of CMSA, explains that most of the food is prepared to be solid, boneless, and in small pieces. Condiments such as pork sauce and Sichuan pepper sauce are used to compensate for the changes in the sense of taste in microgravity. Food items are often adjusted according to astronauts' feedback, such as when larger supplies of vegetables were included in Tianzhou 4. Additionally, China's Tiangong-2 station has conducted experiments growing food on board in a micro-gravity environment, such as thale cress, a form of edible weed, as well as rice.
==== Tax base erosion and the Digital Services Tax ==== The repatriation of AI-generated profits to the US poses a direct threat to the UK tax base. The Fair Tax Foundation's 2025 report on the "Silicon Six" (Alphabet, Amazon, Apple, Meta, Microsoft, and Netflix) found that over the past decade, these companies generated $11 trillion in revenue but paid an effective global corporate tax rate of just 18.8% (falling to 16.1% if one-off repatriation payments are excluded). The report highlighted that aggressive profit-shifting to low-tax jurisdictions means overseas revenue is subject to much lower tax rates than US-booked domestic revenue. To counter this, the UK introduced a Digital Services Tax (DST), a 2% levy on the revenues of search engines, social media services, and online marketplaces. Because it taxes turnover rather than easily shifted profits, the DST is relatively effective, raising £944 million in 2025 alone and projected to raise up to £5.2 billion over the current Parliament. However, the DST has become a major geopolitical flashpoint. US President Donald Trump has repeatedly threatened to impose punitive tariffs on UK exports unless the tax is scrapped, describing such levies as "overseas extortion". Think tanks such as Chatham House and the Royal United Services Institute (RUSI) have warned that if the UK government trades away the DST to secure US tech investment or avoid tariffs, it would surrender crucial regulatory power and signal a profound loss of digital sovereignty over the foundational infrastructure of the modern economy.
Although the preponderance of evidence is on the side of a multidimensional measure, the issue has not been fully resolved owing in part to limitations in the methodological knowledge available on distinguishing between substantive and method variance.
==== Government policy failures and subsidy mismanagement ==== The Iranian government's control of prices through subsidies and other measures frequently backfires. For example, subsidies meant to make essential items affordable are sometimes misappropriated by corrupt officials and traders who sell these goods outside official channels at inflated rates. This diversion exacerbates shortages in the official markets and pushes up prices.
==== Freezing most programs for 90 days ==== DOGE dismantled most of USAID, which had been a 10,000-person agency originally tasked to carry-out humanitarian projects. USAID's critics maintained that many of the projects were in fact not all that humanitarian and/or much of the money was not well spent. In January 2025, the administration issued a 90-day stop-work order worldwide, Stop work interrupted about 30 clinical trials, and interrupted projects such as emergency medical care for displaced Palestinians and Yemenis, aid for war refugees on the Sudan-Chad border, and electricity for Ukrainian refugees. The HIV Modeling Consortium estimated the death toll from HIV in sub-Saharan Africa at approximately 15,000 adults and 1,600 children in the one month after Trump's January 2025 funding freeze. A key controversy is whether or not waivers are being made and money actually starting to flow again for the most essential programs. For example, the Associated Press reported on February 19, that waivers for PEPFAR, the program that has saved 26 million lives from AIDS, were not in force, despite a federal judge having lifted the funding freeze.
Sources: en.wikipedia.org
Henry Dale, a former student of Paul Ehrlich, received the 1936 Nobel Prize in Medicine for his work on the chemical transmission of neural impulses. Dale served as a pharmacologist and then as Director of the Wellcome Physiological Research Laboratories from 1904 to 1914, and later served as Trustee and chairman of the board of the Wellcome Trust. John Vane of Wellcome Research Laboratories shared the 1982 Nobel Prize for Medicine for his work on prostaglandin biology and the discovery of prostacyclin. Vane served as group research and development director for The Wellcome Foundation from 1973 to 1985. Gertrude B. Elion and George Hitchings, both of the Wellcome Research Laboratories, shared the 1988 Nobel Prize in Medicine with Sir James W. Black, formerly of Smith Kline & French and the Wellcome Foundation, ""for their discoveries of important principles for drug treatment"." Elion and Hitchings were responsible for the discovery of a plethora of important drugs, including mercaptopurine and thioguanine for the treatment of leukemia, the immunosuppressant azothioprine, allopurinol for gout, pyrimethamine for malaria, the antibacterial trimethoprim, acyclovir for herpes virus infection, and nelarabine for cancer treatment.
=== Combinatorial library synthesis === Robotics have applications with combinatorial chemistry which has great impact on the pharmaceutical industry. The use of robotics has allowed for the use of much smaller reagent quantities and mass expansion of chemical libraries. The "parallel synthesis" method can be improved upon with automation. The main disadvantage to "parallel-synthesis" is the amount of time it takes to develop a library, automation is typically applied to make this process more efficient. The main types of automation are classified by the type of solid-phase substrates, the methods for adding and removing reagents, and design of reaction chambers. Polymer resins may be used as a substrate for solid-phase. It is not a true combinatorial method in the sense that "split-mix" where a peptide compound is split into different groups and reacted with different compounds. This is then mixed back together split into more groups and each groups is reacted with a different compound. Instead the "parallel-synthesis" method does not mix, but reacts different groups of the same peptide with different compounds and allows for the identification of the individual compound on each solid support. A popular method implemented is the reaction block system due to its relative low cost and higher output of new compounds compared to other "parallel-synthesis" methods. Parallel-Synthesis was developed by Mario Geysen and his colleagues and is not a true type of combinatorial synthesis, but can be incorporated into a combinatorial synthesis.
==== Depression in elderly ==== Sertraline used for the treatment of depression in elderly (older than 60) patients is superior to placebo and comparable to another SSRI, fluoxetine, and tricyclic antidepressants (TCAs) amitriptyline, nortriptyline and imipramine. Sertraline has much lower rates of adverse effects than these TCAs, with the exception of nausea, which occurs more frequently with sertraline. In addition, sertraline appears to be more effective than fluoxetine or nortriptyline in the older-than-70 subgroup. Accordingly, a meta-analysis of antidepressants in older adults found that sertraline, paroxetine and duloxetine were better than placebo. However, in a 2003 trial the effect size was modest, and there was no improvement in quality of life as compared to placebo. With depression in dementia, there is no benefit of sertraline treatment compared to either placebo or mirtazapine.
Biden said, "I view myself as a transition candidate." On August 11, Biden announced Kamala Harris as his running mate, making her the first African American and first South Asian American vice-presidential nominee on a major-party ticket. On August 18, at the 2020 Democratic National Convention, Biden officially became the Democratic Party nominee for president in the 2020 election.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.